Drug Trial Radar · NCT00388297
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy
Last checked: Nov 19, 2026Latest source record: Feb 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,203
Actual
Start
Oct 2006
Primary completion
Aug 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- The George Washington University Biostatistics CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Oct 16, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether treating women, who are diagnosed with a mild imbalance of thyroid hormones during pregnancy, with thyroid hormone replacement affects their children's intellectual development at 5 years of age.
Conditions
- Subclinical Hypothyroidism
- Hypothyroxinemia
- Pregnancy
Interventions
LevothyroxineDrug
Coded study drug is thyroxine encapsulated in a gel capsule; matching placebo contains only cellulose. Color of capsule corresponds to mcg dose level (100mcg or 25 mcg). Subjects in subclinical hypothyroidism stratum are started on 1 capsule of 100 mcg per day; subjects in hypothyroxinemia stratum are started on 2 capsules of 25 mcg per day. Thyroxine dosing adjustments for both strata are determined centrally, using an algorithm, based on results of monthly TSH or free-T4 assays. Subjects take study medication until delivery.
Placebo for LevothyroxineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intellectual Function of Children at 5 Years of Age in Women Diagnosed With a) Subclinical Hypothyroidism or b) Hypothyroxinemia During the First Half of Pregnancy, or Death.Time frame: 60 months of age
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Birmingham
Birmingham, Alabama
Northwestern University
Chicago, Illinois
Wayne State University
Detroit, Michigan
Columbia University
New York, New York
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina
Case Western University
Cleveland, Ohio
Ohio State University
Columbus, Ohio
Oregon Health & Sciences University
Portland, Oregon
University of Pittsburgh Magee Womens Hospital
Pittsburgh, Pennsylvania
Brown University
Providence, Rhode Island
University of Texas - Southwest
Dallas, Texas
University of Texas Medical Branch - Galveston
Galveston, Texas
University of Texas-Houston
Houston, Texas
University of Utah Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.